Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. (Q53730120)

18 May 2018

title

Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. (English)

1 reference

18 May 2018

author name string

F Pajonk

series ordinal

1

1 reference

18 May 2018

K Pajonk

series ordinal

2

1 reference

18 May 2018

W H McBride

series ordinal

3

1 reference

18 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

18 May 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

18 May 2018

volume

47

1 reference

18 May 2018

issue

4

1 reference

18 May 2018

page(s)

1025-1032

1 reference

18 May 2018

A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Clonality in nodular lymphocyte-predominant Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Hodgkin's disease--time for a change

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

A proteolytic system that compensates for loss of proteasome function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

CD40-ligation-mediated protection from apoptosis of a Fas-sensitive Hodgkin's-disease-derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Activation of the cell death program by inhibition of proteasome function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Apoptosis induction resulting from proteasome inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Calpain activation is upstream of caspases in radiation-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Calpain activation in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

The ubiquitin-proteasome proteolytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

The proteasome regulates caspase-dependent and caspase-independent protease cascades during apoptosis of MO7e hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900516-2

7 January 2021

10.1016/S0360-3016(00)00516-2

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018